Stay updated on ARGX-110 with Azacytidine in AML Clinical Trial
Sign up to get notified when there's something new on the ARGX-110 with Azacytidine in AML Clinical Trial page.

Latest updates to the ARGX-110 with Azacytidine in AML Clinical Trial page
- Check3 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content. This indicates restricted access to the NCT03030612 page and blocks viewing the study details in ClinicalTrials.gov.SummaryDifference19%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe study record now includes NIH grant/contract funding information for 2016, and the page revision has been updated to v3.6.6 (replacing the previous v3.6.5).SummaryDifference0.1%

- Check45 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a newer version of the page. This update appears to be an internal revision with no substantive changes to the study details displayed.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, representing a small update to the page's version metadata. There is no indication of substantive changes to the study details or related content.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, signaling a small update to the page's underlying system. No changes to the study details or related content are indicated by this update.SummaryDifference0.1%

- Check88 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a minor, non-substantive update to the record. This reflects a version increment without changing the study information presented.SummaryDifference0.1%

Stay in the know with updates to ARGX-110 with Azacytidine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARGX-110 with Azacytidine in AML Clinical Trial page.